The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Kenzie Cameron, Northwestern University
ClinicalTrials.gov Identifier:
NCT01009645
First received: November 6, 2009
Last updated: August 20, 2012
Last verified: August 2012
  Purpose

The purpose of this study is to evaluate whether message design of educational materials increases vaccination rates among participants.


Condition Intervention
Influenza Vaccination
Behavioral: Fact Only Education Message
Behavioral: Fact and Myth Educational Message
Behavioral: Fact, Myth, Why Educational Message
Behavioral: Control Educational Message

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

Resource links provided by NLM:


Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Influenza Vaccination [ Time Frame: 1 week following randomization ] [ Designated as safety issue: No ]
    The primary outcome is receipt of influenza vaccination at appointment directly following the post-test. A pre-test was completed by participants during a telephone interview that occurred approximately two weeks prior to a scheduled clinic appointment. The post-test was completed via an in-person interview by participants immediately prior to their scheduled appointment. That is, the participants met with the Research Assistant, completed the post-test, and then proceeded to see their physician for a previously scheduled office visit.


Secondary Outcome Measures:
  • Recall Accuracy [ Time Frame: 1 week following receipt of message ] [ Designated as safety issue: No ]
    Participants were given 8 statements about the flu/flu shot and asked to recall if they had seen the statement on the message they received via FedEx. Participants responded that statement had been "presented as a fact," "presented as a myth," "presented, but I don't recall if it was a fact or a myth," or "not presented." Participants scored 1 for each correct answer; 0 for each incorrect answer or for response "I don't recall." Recall accuracy was calculated among each message format, range for recall accuracy was 0 - 8 with 0 indicating no correct answers and 8 representing 100% accuracy. Thus units of measurement are "units on a scale" to represent participant scores out of 8 on the recall items.


Enrollment: 125
Study Start Date: September 2009
Study Completion Date: April 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Fact Only
The educational message used will contain facts only.
Behavioral: Fact Only Education Message
Participants randomized to this intervention will receive an educational brochure listing the facts of the influenza vaccine.
Other Name: Fact Only
Experimental: Fact and Myth
The educational material seen by this arm will contain facts and myths only.
Behavioral: Fact and Myth Educational Message
Participants randomized to this intervention will receive an educational brochure listing the facts and myths of the influenza vaccine.
Other Name: Fact & Myth
Experimental: Fact, Myth, Why
The educational material seen by this arm will contain myths, facts, and refutations of the myths.
Behavioral: Fact, Myth, Why Educational Message
Participants randomized to this intervention will receive an educational brochure listing the facts, myths, and refutation of the myths of the influenza vaccine.
Other Name: Fact, Myth, Why
Placebo Comparator: Control
This arm will receive fact/myth educational materials originally developed and used by the CDC.
Behavioral: Control Educational Message
Participants randomized to this intervention will receive an educational brochure created and used by the CDC in a previous influenza season.
Other Name: Control

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participant must have a scheduled appointment at least 6 weeks in advance in either the GIM or Geriatrics clinics at NMFF.
  • Participant must be a patient of Northwestern Medical Faculty Foundation.
  • Participant does not intend to receive the influenza vaccine.

Exclusion Criteria:

  • Participant has a diagnosis of Alzheimer's Disease or Dementia
  • Participant has received an influenza vaccination during either the last influenza season or the current.
  • The scheduled visit is the participant's first time being seen by this doctor (appointment is to establish care in the clinic).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01009645

Locations
United States, Illinois
Northwestern Medical Faculty Foundation General Internal Medicine and Geriatric Clinics
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
  More Information

No publications provided

Responsible Party: Kenzie Cameron, Research Associate Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT01009645     History of Changes
Other Study ID Numbers: Fact versus Myth Messages, 1R21AG031470-01
Study First Received: November 6, 2009
Results First Received: April 25, 2012
Last Updated: August 20, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Northwestern University:
education
vaccination
preventive service
Prevention & Control

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 21, 2013